NEW YORK, April 27 (GenomeWeb News) - Illumina today reported a 40-percent gain in first-quarter revenues, as total receipts for the quarter ended April 3 climbed to $15.1 million from $10.8 million year over year.

R&D spending increased 13 percent to $5.9 million from $5.2 million in the first quarter of 2004.

Net loss for the quarter fell to $1.2 million, or $.03 per share, from $3.9 million, or $.12 per share, in the first quarter of 2004.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.